Get the Stockscreener App
3.62
11.04%
0.36
After Hours:
3.44
-0.18
-4.97%
Kazia Therapeutics Limited Adr Stock (KZIA) Forecast
The Kazia Therapeutics Limited Adr (KZIA) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.6468, representing a -82.13% decrease from the current price of $3.62. The highest analyst price target is $1.0468, and the lowest is $0.2468.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month KZIA Price Target
Average 7.0484
(+94.71% Upside)
Is Kazia Therapeutics Limited Adr (KZIA) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 48.45 | Neutral |
| STOCH(9,6) | 30.02 | Neutral |
| STOCHRSI(14) | 77.94 | Neutral |
| MACD(12,26) | -0.1926 | Buy |
| ADX(14) | 17.21 | Neutral |
| William %R | -51.54 | Neutral |
| CCI(14) | 11.93 | Neutral |
Buy: 1
Sell: 0
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
3.517
Buy
|
3.4712
Buy
|
| MA20 |
3.5172
Buy
|
3.578
Buy
|
| MA50 |
4.0431
Sell
|
4.5148
Sell
|
| MA100 |
6.3476
Sell
|
7.3026
Sell
|
| MA200 |
14.11
Sell
|
10.86
Sell
|
Buy: 4
Sell: 6
Neutral: 0
Summary: Sell
According to our latest analysis, KZIA could be considered a Neutral, with 17 technical analysis indicators signaling 5 Buy signals, 6 signaling Sell signals and 6 Neutral signals. This suggests that investors should exercise caution when entering new positions on KZIA, as the market is likely to remain volatile in the near term.
- RSI (Relative Strength Index): The RSI(14) value of 48.45 indicates that KZIA is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 30.02 indicates that KZIA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 77.94 indicates that KZIA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 17.21 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 11.93 indicates that KZIA is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term KZIA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Kazia Therapeutics Limited Adr financial reports and earnings history, Kazia Therapeutics Limited Adr (KZIA) stock could reach $2.3518 by 2030, $1.2706 by 2040 and $0.1999 by 2050. See the projected annual prices until 2050 of the Kazia Therapeutics Limited Adr stock below:
- Kazia Therapeutics Limited Adr (KZIA) is expected to reach an average price of $0.3116 in 2035, with a high prediction of $0.5092 and a low estimate of $0.3708. This indicates an $-91.39% rise from the last recorded price of $3.62.
- Kazia Therapeutics Limited Adr (KZIA) stock is projected to chart a bullish course in 2040, with an average price target of $1.0485, representing an $-71.04% surge from its current level. The forecast ranges from a conservative $1.0991 to a sky-high $1.2706.
- Our analysts predict Kazia Therapeutics Limited Adr (KZIA) to jump -11.03% by 2045, soaring from $3.0869 to an average price of $3.2206, potentially reaching $3.0894. While $3.0869 is the low estimate, the potential upside is significant.
- Kazia Therapeutics Limited Adr (KZIA) stock is expected to climb by 2050, reaching an average of $0.2999, a $-91.72% jump from its current level. However, a wide range of estimates exists, with high and low targets of $0.1999 and $0.2665, respectively, highlighting the market's uncertainty.
Kazia Therapeutics Limited Adr Stock (KZIA) Year by Year Forecast
Kazia Therapeutics Limited Adr Stock (KZIA) Price Forecast for 2025
Kazia Therapeutics Limited Adr Stock (KZIA) is expected to reach an average price of $3.2997 in 2025, with a high prediction of $6.4287 and a low estimate of $0.1708. This indicates an -8.85% fall from the last recorded price of $3.62.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2025 | $0.4668 | $0.2468 | $1.0468 | -87.11% |
| July, 2025 | $1.059 | $0.3552 | $1.2521 | -70.75% |
| August, 2025 | $1.3227 | $0.9575 | $1.7671 | -63.46% |
| September, 2025 | $4.2465 | $1.0812 | $6.0465 | +17.31% |
| October, 2025 | $5.2487 | $3.1749 | $6.4287 | +44.99% |
| November, 2025 | $4.6825 | $4.334 | $5.2795 | +29.35% |
| December, 2025 | $3.8647 | $3.5247 | $4.4894 | +6.76% |
Kazia Therapeutics Limited Adr Stock (KZIA) Price Forecast for 2026
The predicted value for Kazia Therapeutics Limited Adr (KZIA) in 2026 is set at an average of $8.7016. Estimates vary from a peak of $13.85 to a trough of $3.5531, indicating an +140.37% surge from the present price of $3.62.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $8.1885 | $3.5531 | $13.85 | +126.20% |
| February, 2026 | $7.1622 | $6.8422 | $8.8738 | +97.85% |
| March, 2026 | $8.176 | $6.5391 | $8.5376 | +125.86% |
| April, 2026 | $9.8182 | $7.4014 | $10.77 | +171.22% |
| May, 2026 | $9.602 | $6.6451 | $11.35 | +165.25% |
| June, 2026 | $11.81 | $8.9154 | $13.08 | +226.13% |
| July, 2026 | $7.8679 | $7.328 | $11.79 | +117.35% |
| August, 2026 | $8.7317 | $7.2448 | $10.20 | +141.21% |
| September, 2026 | $7.9039 | $7.6786 | $9.5101 | +118.34% |
| October, 2026 | $7.2877 | $7.0508 | $8.1023 | +101.32% |
| November, 2026 | $9.2214 | $6.9561 | $9.3714 | +154.74% |
| December, 2026 | $9.7337 | $8.3983 | $10.40 | +168.89% |
Kazia Therapeutics Limited Adr Stock (KZIA) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Kazia Therapeutics Limited Adr (KZIA) is $5.6035, with a high forecast of $10.74 and a low forecast of $0.4626. This indicates an +54.79% increase from the last price of $3.62.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $9.1874 | $7.939 | $10.12 | +153.80% |
| February, 2027 | $9.8512 | $8.8559 | $10.74 | +172.13% |
| March, 2027 | $6.1219 | $5.4084 | $9.7396 | +69.11% |
| April, 2027 | $6.3572 | $5.7581 | $7.4403 | +75.61% |
| May, 2027 | $5.1709 | $4.594 | $6.8456 | +42.84% |
| June, 2027 | $5.1831 | $4.9031 | $6.5878 | +43.18% |
| July, 2027 | $6.3769 | $4.44 | $7.1268 | +76.16% |
| August, 2027 | $6.1307 | $5.7822 | $7.2938 | +69.36% |
| September, 2027 | $4.8229 | $3.736 | $6.2341 | +33.23% |
| October, 2027 | $4.0466 | $3.7966 | $5.1566 | +11.79% |
| November, 2027 | $2.8804 | $2.612 | $3.9051 | -20.43% |
| December, 2027 | $0.6426 | $0.4626 | $2.8989 | -82.25% |
Kazia Therapeutics Limited Adr Stock (KZIA) Price Forecast for 2028
In 2028, Kazia Therapeutics Limited Adr (KZIA) is projected to reach an average price of $0.4418, with a high projection of $0.8787 and a low estimate of $0.00492. This indicates an -87.79% fall from the last price of $3.62.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.3064 | $0.2479 | $0.7611 | -91.54% |
| February, 2028 | $0.0202 | $0.00985 | $0.5548 | -99.44% |
| March, 2028 | $0.2113 | $0.0114 | $0.2739 | -94.16% |
| April, 2028 | $0.3641 | $0.3691 | $0.3639 | -89.94% |
| May, 2028 | $0.4173 | $0.3791 | $0.3718 | -88.47% |
| June, 2028 | $0.0821 | $0.0579 | $0.327 | -97.73% |
| July, 2028 | $0.0619 | $0.024 | $0.139 | -98.29% |
| August, 2028 | $0.1481 | $0.0112 | $0.3396 | -95.91% |
| September, 2028 | $0.3118 | $0.00492 | $0.3657 | -91.39% |
| October, 2028 | $0.4356 | $0.2403 | $0.8787 | -87.97% |
| November, 2028 | $0.4678 | $0.3109 | $0.6224 | -87.08% |
| December, 2028 | $0.4516 | $0.4016 | $0.6063 | -87.53% |
Kazia Therapeutics Limited Adr Stock (KZIA) Price Forecast for 2029
The 2029 price forecast for Kazia Therapeutics Limited Adr Stock (KZIA) is $1.12 on average, with a high prediction of $2.2326 and a low estimate of $0.00731. This represents an -69.06% decrease from the previous price of $3.62.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.3438 | $0.1269 | $0.58 | -90.50% |
| February, 2029 | $0.2186 | $0.2111 | $0.4422 | -93.96% |
| March, 2029 | $0.4113 | $0.227 | $0.5429 | -88.64% |
| April, 2029 | $0.1151 | $0.0688 | $0.4882 | -96.82% |
| May, 2029 | $0.1173 | $0.0215 | $0.2475 | -96.76% |
| June, 2029 | $0.0379 | $0.0389 | $0.3641 | -98.95% |
| July, 2029 | $0.0157 | $0.0692 | $0.0583 | -99.57% |
| August, 2029 | $0.114 | $0.0667 | $0.0486 | -96.85% |
| September, 2029 | $0.0712 | $0.1203 | $0.0961 | -98.03% |
| October, 2029 | $0.0671 | $0.116 | $0.1154 | -98.15% |
| November, 2029 | $0.0728 | $0.0256 | $0.1863 | -97.99% |
| December, 2029 | $2.4526 | $0.00731 | $2.2326 | -32.25% |
Kazia Therapeutics Limited Adr Stock (KZIA) Price Forecast for 2030
Kazia Therapeutics Limited Adr Stock (KZIA) is expected to reach an average price of $2.594 in 2030, with a high forecast of $4.7608 and a low forecast of $0.4273. This signifies an -28.34% decrease from the last price of $3.62.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $2.7782 | $2.5319 | $2.3518 | -23.25% |
| February, 2030 | $2.6706 | $2.8106 | $2.7794 | -26.23% |
| March, 2030 | $2.7331 | $2.70 | $2.6702 | -24.50% |
| April, 2030 | $2.8856 | $2.9125 | $2.8856 | -20.29% |
| May, 2030 | $1.2412 | $1.4812 | $2.7433 | -65.71% |
| June, 2030 | $1.8736 | $1.8736 | $1.7636 | -48.24% |
| July, 2030 | $2.4208 | $1.7092 | $4.7608 | -33.13% |
| August, 2030 | $0.7517 | $0.7286 | $2.4677 | -79.24% |
| September, 2030 | $0.2841 | $0.5341 | $0.361 | -92.15% |
| October, 2030 | $0.6347 | $0.4273 | $0.5197 | -82.47% |
| November, 2030 | $0.7922 | $0.776 | $0.5579 | -78.12% |
| December, 2030 | $2.0222 | $1.9666 | $1.8447 | -44.14% |
0.84%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):